Cymene consumption and physical activity effect in Alzheimer's disease model: an in vivo and in vitro study
- PMID: 33520841
- PMCID: PMC7843760
- DOI: 10.1007/s40200-020-00658-2
Cymene consumption and physical activity effect in Alzheimer's disease model: an in vivo and in vitro study
Abstract
Purpose: Alzheimer's disease (AD) is one of the most important neurodegenerative diseases and accompanied by the production of free radicals and inflammatory factors. Studies have shown that p-cymene has anti-inflammatory and anti-oxidant effects. Here, the effects of this compound were investigated on a rat model of AD.
Methods: In order to create Alzheimer's rat model, bilateral injection of Amyloid β1-42 (Aβ1-42) into rats hippocampus was performed. Both therapeutic (post-AD induction) and preventive effects of p-cymene consumption with doses of 50 and 100 mg/kg were investigated. In addition, the effects of adding short-term exercise to the process were also observed. In vitro, Aβ1-42 peptide was driven toward fibril formation and effect of p-cymene was observed on the resulting fibrils.
Results: Learning and memory indices in the AD rats were significantly reduced compared to the Sham group, while p-cymene consumption with both doses, as well as performing exercise counteracted AD consequences. Moreover, increased neurogenesis and reduced amyloid plaques counts were observed in treated rats. In vitro formed fibrils of Aβ1-42 were partially disaggregated in the presence of p-cymene.
Discussion: p-Cymene could act on this AD model via antioxidant and anti-inflammatory properties as well as direct anti-fibril effect.
Conclusion: p-cymene can improve AD-related disorders including memory impairment.
Keywords: Alzheimer’s disease; Aβ1–42; Cymene; Fibril; Rat.
© Springer Nature Switzerland AG 2020.
Conflict of interest statement
Conflict of interestAll authors declare to have no conflict of interests.
Figures



References
-
- Solanki I, Parihar P, Parihar MS. Neurodegenerative diseases: from available treatments to prospective herbal therapy. Neurochem Int. 2015;95:100–108. - PubMed
-
- Drachman D. Aging of the brain, entropy, and Alzheimer disease. Neurology. 2006;67(8):1340–1352. - PubMed
-
- Duthey B. Alzheimer disease and other dementias,Priority Medicines for Europe and the World. A Public Health Approach to Innovation. 2004:1–74.
-
- de Sousa DP, Gonçalves JCR, Quintans-Júnior L, Cruz JS, Araújo DAM, de Almeida RN. Study of anticonvulsant effect of citronellol, a monoterpene alcohol, in rodents. Neurosci Lett. 2006;401:231–235. - PubMed
-
- Nerio LS, Olivero-Verbel J, Stashenko E. Repellent activity of essential oils: a review. Bioresour Technol. 2010;101:372–378. - PubMed
LinkOut - more resources
Full Text Sources